Compare patent estates

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pick 2-4 drugs to compare side-by-side: portfolio size, vulnerability distribution, cliff calendar, strongest defences, most attackable patents.

Quick comparisons

keytruda vs opdivo vs tecentriqhumira vs enbrel vs remicadeozempic vs mounjaro vs wegovyimbruvica vs calquence vs brukinsa

Why compare estates?

BD evaluation — when assessing an in-licensing target, compare its patent fortress to the rivals it would face on launch
Biosimilar / generic strategy — pick targets where the patent fortress is materially weaker than competitors in the class
Investor due diligence — compare a pipeline asset's eventual fortress against the leader in its class
Settlement modelling — for Hatch-Waxman cases, benchmark settlement reasonableness against estates with similar vulnerability profiles